Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused
Futura Medical PLC (FUM.L) US FDA Agreement for Confirmatory Clinical study
Futura Medical Receives US FDA Agreement for Confirmatory Clinical study, FM71 for MED3000
Futura Medical PLC (FUM.L) Futura Announces Investment & Joint Collaboration
Futura Medical Announces Investment and Joint Collaboration to Commercialise MED3000 in China and South East Asia